INFANTS' TYLENOL ORAL SUSPENSION OTC
Generic Name and Formulations:
Acetaminophen 160mg/5mL; cherry or grape flavor; alcohol-free.
McNeil Consumer Healthcare
Indications for INFANTS' TYLENOL ORAL SUSPENSION:
Minor aches and pain. Fever.
Dispense liquid slowly in mouth toward inner cheek. <24lbs or <2yrs: consult doctor. 24–35lbs or 2–3yrs: 5mL (160mg) every 4hrs; max 5 doses/24hrs.
Hepatic dysfunction. Reevaluate if severe sore throat persists >2 days with or followed by fever, headache, rash, nausea or vomiting. Discontinue if new symptoms occur, pain worsens >5 days, fever persists >3 days, or if redness or swelling is present.
Do not use with other acetaminophen-containing drugs. Caution with concomitant warfarin.
Susp (w. oral syringe)—1oz (grape); 2oz (cherry)
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Fatigue Management Contributes to Effective Endometriosis Care
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
- New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D
- Peer-Led Education Helps Physicians Save Time With EHRs
- As Immigration Policies Tighten, Physician Shortage Concerns Grow